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The abundance of Akkermansia
muciniphila and its relationship
with sulphated colonic mucins in
health and ulcerative colitis
Helen Earley1,2,5*, Grainne Lennon1,2,5, Áine Balfe4, J. Calvin Coffey3, Desmond C. Winter2 &
P. Ronan O’Connell 1,2
Akkermansia muciniphila utilises colonic mucin as its substrate. Abundance is reduced in ulcerative
colitis (UC), as is the relative proportion of sulphated mucin in the mucus gel layer (MGL). It is unknown
if these phenomena are related, however reduced sulphated mucins could contribute to reduced
abundance, owing to a lack of substrate. The aim of this study was to quantify A. muciniphila within
the MGL and to relate these findings with markers of inflammation and the relative proportion of
sulphomucin present. Colonic biopsies and mucus brushings were obtained from 20 patients with
active UC (AC), 14 with quiescent UC (QUC) and 20 healthy controls (HC). A. muciniphila abundance
was determined by RT-PCR. High iron diamine alcian-blue staining was performed for histological
analysis. Patients with AC had reduced abundance of A. muciniphila compared to HC and QUC. A
positive association was found between A. muciniphila abundance and higher percentage of sulphated
mucin (ρ 0.546, p = 0.000). Lower abundances of A. muciniphila correlated with higher inflammatory
scores (ρ = 0.294 (p = 0.001)). This study confirms an inverse relationship between A. muciniphila and
inflammation and a positive association between A. muciniphila abundance and percentage of sulfated
mucin in the MGL.
The Akkermansia genus is present abundantly in the human gastrointestinal tract where it is believed to be a key
symbiont member of the microbiota1–5. Since its discovery, evidence is accumulating suggesting a beneficial role
for A. muciniphila4,6–9. The species has the ability to modulate host immune responses and may play a role in
immune-tolerance to commensal microbes6.
Significant reductions in A. muciniphila have been demonstrated in both faecal samples and mucosal biopsies
of patients with UC8,10–12. Germ free mice colonised with A. muciniphila do not develop microscopically visible
inflammation, strengthening the argument for a protective role of this microbe in the setting of UC6. To date, the
potential factors contributing to the reduced abundance of this species in UC have not been explored.
The mucus gel layer (MGL), comprised predominantly of mucins, represents the host microbial interface in
the human colon. It is composed of a loosely adherent outer layer, which is home to the resident microbiota and a
densely adherent inner layer which prevent bacterial penetration to the epithelium13. Quantitative and qualitative
changes occur within the MGL in UC, including depletion of the layer, altered glycosylation and alterations of
the proportions of sulphated and sialyated mucin14–16. Such changes alter the microenvironment in which the
commensal microbiota resides, which may have implications for their survival. A. muciniphila utilises mucin as
its substrate and the species has the propensity to produce several mucolytic enzymes, one of which is a sulfatase,
which cleaves the terminal sulfate moiety of mucin17. Biochemical alterations in mucin such as in UC may therefore impact bacterial growth.
To date, published data pertaining to A. muciniphila abundance have derived from studies employing either
faecal samples or whole mucosal biopsies. A degree of spatial variation exists across the cross sectional axis of
the human colon, with distinct microbial communities residing in the luminal contents, mucus and mucosa18–20.
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Therefore, neither of these sampling methods reflect the microbial composition at the host microbial interface.
Brushings of the MGL facilitate optimum study of the innate microbiota that is stable over space and time, owing
to the fact that the layer is enriched with microbial DNA and communities within it are less susceptible to changes
related to dietary factors when compared with other sampling methods20,21.
The aim of this study was to perform quantitative analysis of A. muciniphila within the MGL in health and in
patients with UC and to correlate these findings with markers of colonic inflammation and the relative proportion
of sulphated mucin present within the MGL.

Materials and Methods

Ethical approval, patient recruitment and sample collection. Ethical approval was obtained from
the St. Vincent’s University Hospital Ethics and Medical Research Committee Version 7, 2012. All methods were
carried out in accordance with this. All participants were over 18 years of age and gave written informed consent.
Three patient cohorts were established for this study: healthy controls (HC), patients with quiescent UC (QUC)
and patients with active UC (AC).
Healthy volunteers were recruited before undergoing routine diagnostic day case colonoscopy. No macroscopic evidence of mucosal pathology was evident in these individuals. Patients were excluded from the study if
they had a history of antibiotic usage or hospital admission in the six weeks prior to colonoscopy, personal history of irritable bowel syndrome (IBS), indeterminate colitis, gastrointestinal malignancy or previous colorectal
surgery.
Patients with quiescent UC were identified as having been previously diagnosed with histologically confirmed
UC and who were undergoing surveillance colonoscopy. Exclusion criteria were as above or evidence of UC
associated dysplasia. The bowel preparations received by all patients undergoing colonoscopy were polyethylene
glycol and sodium picosulphate based.
Patients in the AC cohort were recruited prior to undergoing surgical resection for disease refractory to medical management or those with AC failing to respond to rescue therapy (intravenous steroids, biologics or cyclosporine). Patients had not received bowel preparation prior to undergoing surgery, but had received a single dose
of intravenous antibiotics prior to induction of anaesthesia, as per Hospital protocol. MAYO scores of disease
severity22 were available for all patients included in the study. These were calculated as outlined in Supplementary
Table 1.
Patients were excluded from further consideration if they had been prescribed oral or intravenous antibiotics
in the previous 3 months, had a history of colon cancer, colonic resection or active GI bleeding, were residents of
a long-term care facility or had been a hospital inpatient within the previous 6 weeks.
To obtain mucus brushings, a Hobbs’ Microbiological Protected Specimen Brush (PSB) (Hobbs Medical
Inc., CT 06076, U.S.A,) was advanced at colonoscopy in a protective sheath, deployed under direct vision and
brushed multiple times until coated, as previously described20. It was closed under direct vision and retracted
through the colonoscope port. Radial Jaw 3 biopsy forceps (Boston Scientific, Cork, Ireland) were used to target
a region immediately adjacent to that which had been directly sampled by the PSB and a whole mucosal biopsy
retrieved for histological analysis. Samples were stored in sterile 1.5 ml micro-centrifuge tubes on dry ice until
DNA extraction.
DNA extracts were isolated from colonic mucus brushings and stored in sterile micro-centrifuge tubes at
−20 °C. DNA was extracted using a Qiagen DNA mini kit (Qiagen, Hilden, Germany). Paired formalin-fixed
and paraffin-embedded mucosal biopsies were also obtained for histological analysis. The biobank of samples
consisted of DNA from 20 HCs, 14 patients with QUC and 20 patients with AC. For each patient, samples were
collected from four areas of the colon; caecum, transverse colon, left colon and rectum.

®

Histological analysis of specimens. Formalin fixed, paraffin embedded mucosal biopsy specimens for
each mucin sample were stained using Haematoxylin and eosin stain (H&E) and High Iron Diamine-Alcian
Blue (HID-AB) staining to quantify degree of inflammation and percentage sulphation respectively as previously
described15,23 (Fig. 1). For each specimen, the quantity of sulphated mucin was determined and results expressed
as the percentage relative to the total mucin content for a given specimen. For histological analysis, UC specimens
were scored as mild, moderate or severe inflammation, according to the system described by Geboes et al.24.
Construction of plasmid DNA standards.

A series of plasmid DNA standards was generated to enable calculation of A. muciniphila copy number in each sample. In brief, freeze dried cultures of A. muciniphila reference strain ATCC BAA-835 (American Type Culture Collection, Manassas, VA, U.S.A.) were cultured
according to manufacturer’s instructions in Brain Heart Infusion (BHI) medium (Sigma Aldrich , Dublin,
Ireland). Cultures were placed in a shaking incubator at 200 rpm at 37 °C for 16 hours under anaerobic conditions achieved by the use of AnaeroGen anaerobic gas packs (Oxoid, Basingstoke, UK). DNA was extracted
using a series of four heat freeze cycles at −80 °C and 100 °C. Conventional PCR targeting the 16S rRNA gene
of A. muciniphila was performed using oligonucleotide primers targeting A. muciniphila (forward primer 5′CAGCACGTGAAGGTGGGGAC – 3′ reverse primer 5′- CCTTGCGGTTGGCTTCAGAT-3′)10. All PCR reactions contained 1X My Taq Red Mix (Bioline, London, UK), forward primer and reverse primer at a final
concentration of 200 nM. The 327 bp amplicon generated and cloned into a TOPO vector using the TOPO TA
cloning system. DNA from the recombinant plasmid mini-preps was purified using the QIAprep Spin MiniPrep
kit (Qiagen). The total weight per recombinant plasmid was calculated and this was used to generate a series of
DNA standards of known copy number of the target sequence.

®
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Figure 1. Section of healthy mucosal biopsy stained by HID/AB at magnification 20X. Sulphated mucins are
mahogany in colour and sialyated mucins are turquoise blue. The resulting hue, saturation and brightness are
used by ImageJ software for colour thresholding23.

Cohort

n

Median Copy
Number

IQR

Cohort
Comparison

HC

20

4.25E + 7

1.26E + 8

HC vs QUC

0.176

QUC

13

1.20E + 7

5.68E + 7

HC vs AC

0.000

AC

20

3.97E + 4

9.99E + 5

QUC vs AC

0.000

p-value

Table 1. Median total bacterial copy number/mg of mucus for each patient cohort. p-values of statistical
comparisons of total bacterial counts between patient cohorts.

Quantification of A. muciniphila in mucus brushings. For each clinical sample the total copy number
of bacteria per mg of mucus had previously been determined by quantitative RT-PCR. Conventional PCR analysis targeted the bacterial 16S rRNA gene (forward primer 5′-TCCTACGGGAGGCAGCAGT-3′, reverse primer
5′-GGACTACCAGGGATCT AATCCTGTT-3′) (Eurofins MWG)25.
RT PCR using an assay specific for the 16S rRNA gene of A. muciniphila was performed using primers detailed
above. All reactions were carried out on an Applied Biosystems 7900HT Fast Real-Time PCR machine (Applied
Biosystems Foster City, CA, USA.). Each reaction was performed in duplicate and carried out in an optical grade
384-well plate at a final volume of 20 µl. Each reaction consisted of 1X Syber Green PCR Master Mix (Applied
Biosystems), forward and reverse primers at final concentration of 200 nM and 4 µl of template Standard cycling
conditions and melt curve analysis were employed, plus an additional annealing stage at 79 °C for 10 sec.

®

®

®

Data analysis. Data analysis for PCR assays performed on the Applied Biosystems platform was performed using

®

SDS 2.4 software (Applied Biosystems ). Target copy number in each sample was determined based on the fold change
(2−∆Ct) relative to the 107 DNA standard. Copy numbers were normalised for dilution volume, elution volume, DNA
concentration and sample weight. Normalised data were exported to SPSS statistics, version 20.0 (SPSS statistics, IBM ,
London, U.K.) for statistical analysis. Data were tested for normality of distribution, and statistical comparisons were
performed based on Mann-Whitney U test, Spearman-Rho and Kruskal-Wallis comparisons.

®

Results

Total bacterial abundance in the mucus gel layer. Data pertaining to the total bacterial counts in the mucus

brush sample were generated using RT-PCR and primers targeting pan-bacterial 16S rRNA gene20. Median copy numbers of total bacterial 16S rRNA expressed per mg of mucus are given in Table 1. Subsequent inter-cohort statistical
analysis was performed based on the Mann Whitney U test, revealing a reduction in total bacterial copy numbers in
AC compared to HC (Fig. 2a, Table 1.) A significant reduction was also observed in AC compared to QUC. No difference was observed between the HC and QUC cohorts. Loco-regional analysis of four colonic areas; caecum, left colon,
transverse colon and rectum revealed the same trend (Table 2). These data were used for normalisation of RT-PCR data
for A. muciniphila, in order to determine the proportional abundance of this microbe in mucus brush samples.

Analysis of paired mucosal biopsy samples for the percentage sulphated mucin and inflammatory cell infiltrate. Median values for the percentage sulphated mucin present in each of the three
patient cohorts are outlined in Table 3. The proportion of sulphated mucin was reduced in AC compared to HC
(p < 0.005) and patients with QUC (p < 0.005).
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Figure 2. (a) Boxplots representing the total bacterial copy number in each cohort. (b) Boxplots representing
Inter-cohort comparisons of A. muciniphila abundance. Patients with acute UC are represented by red,
quiescent UC in orange and healthy controls in green. *represents a significant difference (p < 0.05) (c)
Comparison of A. muciniphila copy number across the longitudinal axis of the colon in the three patient
cohorts.
HC
n

Median

QUC
IQR

n

Median

AC
IQR

n

Median

Inter-cohort Comparisons
IQR

HC-QUC

HC-AC

QUC-AC

Total Bacterial Copy number
Caecum

20

5.07E + 7

1.17E + 8

13

1.54E + 7

2.65E + 7

19

1.47E + 5

1.07E + 6

0.065

0.000

0.002

Transverse

19

4.24E + 6

1.94E + 8

13

7.45E + 6

9.61E + 7

19

9.22E + 4

5.40E + 6

0.001

0.001

0.011

Left

19

6.20E + 7

2.12E + 8

13

1.53E + 7

4.21E + 8

19

2.11E + 5

2.68E + 6

0.935

0.001

0.002

Rectum

20

1.74E + 7

6.39E + 7

13

1.27E + 7

6.44E + 6

18

1.24E + 4

3.41E + 5

0.845

0.000

0.000

IQR

n

IQR

n

IQR

HC-QUC

HC-AC

QUC-AC

A. muciniphila Copy number
n

HC
Median

QUC
Median

AC
Median

Caecum

20

8.12E + 03

1.94E + 05

11

2.46E + 03

1.14E + 04

16

1.84E + 00

2.35E + 00

0.364

0.100

0.000

Transverse

18

7.74E + 03

3.87E + 04

11

1.72E + 03

4.70E + 04

13

7.15E-01

2.08E + 00

0.620

0.000

0.000

Left

16

5.44E + 03

3.66E + 04

12

2.40E + 03

3.25E + 04

18

2.74E + 00

3.02E + 00

0.516

0.000

0.000

Rectum

20

2.99E + 03

8.29E + 04

12

2.82E + 03

2.03E + 04

17

1.46E + 00

3.79E + 00

0.640

0.000

0.000

IQR

n

IQR

HC-QUC

HC-AC

QUC-AC

Normalised A. muciniphila Copy number
n

HC
Median

IQR

n

QUC
Median

AC
Median

Caecum

20

1.45E-04

1.21E-02

11

1.85E-04

9.51E-03

16

3.24E-06

1.40E-04

0.741

0.010

0.103

Transverse

18

5.18E-04

7.85E-03

11

2.58E-04

5.45E-04

13

1.29E-06

1.61E-04

0.393

0.028

0.077

Left

16

9.38E-05

8.45E-03

12

8.20E-05

1.67E-03

18

2.08E-05

9.14E-04

0.486

0.190

0.703

Rectum

20

8.12E-04

7.51E-03

12

1.25E-04

2.18E-03

17

2.82E-95

1.72E-03

0.259

0.072

0.425

Table 2. Total bacterial and A. muciniphila copy numbers compared on a Loco-regional basis across the
longitudinal axis of the colon. Comparison of A. muciniphila copy number on a Loco-regional basis before and
after normalisation against total bacterial copy number.
Inflammatory scores were grouped into three categories according to their histological scores: no inflammation, mild to moderate inflammation and severe inflammation according to a modified version of the scoring
system by Geobes et al. A score of 0–1 was deemed none/mild inflammation, a score of 2–3.3 moderate inflammation and 4–4.5 severe inflammation (Table 3).

Analysis of A. muciniphila in the colonic mucus gel layer.

Relative quantitation was performed using
RT-PCR to determine the copy numbers of the mucolytic species A. muciniphila in AC and QUC compared to
HC. A. muciniphila was detected in all individuals in the AC and HC cohorts and in 13 out of the 14 individuals
in the QUC cohort. No difference in A. muciniphila raw copy number was observed between the four colonic
regions sampled (Kruskall-Wallis p = 0.079).
Statistical comparisons between cohorts were performed using the non-parametric Mann-Whitney U test.
A. muciniphila was significantly less abundant in the AC patient cohort than in the HC or QUC patient cohort
(Fig. 2b, Table 4). No difference was observed between the HC cohort and the QUC patient cohort. Data were
normalised against total bacterial copy number. After normalisation, the same trend was observed (Table 4).
The reduction in abundance of A. muciniphila in the AC cohort compared to HC and QUC was observed in all
four areas of the colon, caecum, transverse colon, left colon and rectum (Fig. 2c, Table 2).
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Mild/
None (n) moderate(n)

Severe
(n)

Caecum

15

0

0

Transverse

16

0

0

Left

9

0

0

Cohort

HC

QUC

AC

Rectum

18

0

0

Caecum

2

2

0

Transverse

0

5

2

Left

0

2

2

Rectum

0

4

1

Caecum

1

3

7

Transverse

1

4

7

Left

0

5

9

Rectum

0

4

8

Median
Sulphomucin (%)

IQR (%)

91.31

14.9

80.39

29.39

47.57

23.49

Table 3. Median percentage sulphomucin and inflammatory scores in each of the three patient cohorts.
Cohort

n

Median Copy No.

IQR

Cohort Comparison

p value

HC

20

5.73E + 03

4.56E + 04

HC-QUC

0.190

QUC

14

1.74E + 03

2.92E + 04

HC-AC

0.000

AC

20

1.80E + 00

2.89E + 00

QUC - AC

0.000

Cohort

n

Median Normalised
Copy No.

IQR

Cohort Comparison

p value

HC

20

2.58E-03

6.69E-04

HC-QUC

0.175

QUC

14

1.86E-04

9.77E-04

HC-AC

0.000

AC

20

2.04E-05

2.17E-04

QUC - AC

0.020

Table 4. Median copy number/mg and relative abundance of A. muciniphila after normalisation for pan
bacterial copy number in each patient cohort. p values for inter-cohort comparisons. Significant values are
highlighted in bold text.

After normalisation of data against total bacterial copy number, a significant reduction in A. muciniphila was
noted in the AC cohort compared to HC in the caecum and transverse colon only (Table 2).

Correlations between A. muciniphila abundance and inflammatory cell infiltrates and percentage of sulphated mucin. To determine whether the reduction in abundance of A. muciniphila in UC was

associated with inflammation, correlations with inflammatory scores were performed. These were grouped into
three categories according to their histological scores: no inflammation, mild to moderate inflammation and
severe inflammation.
Lower abundances of A. muciniphila correlated strongly with higher inflammatory scores, as determined by
the Spearman Rho correlation (ρ = −0.639 (p < 0.005)). After normalisation of the data against total bacterial
copy number a weaker negative correlation was observed (ρ = 0.294 (p = 0.001)).
To determine whether the altered abundance of A. muciniphila in the inflamed colon was associated with
changes in the proportion of sulphated mucin present, correlations between A. muciniphila copy number and the
percentage sulphated mucin were performed.
The proportion of sulphated mucin was reduced in the AC cohort compared to healthy controls (p < 0.005)
(Fig. 3a). This significant reduction in the acute UC cohort was observed across all four colonic regions examined
(Fig. 3a). The distribution of sulfomucin was uniform along the longitudinal axis of the colon (Kruskal Wallis
p = 0.174).
The effect of inflammation on degree of mucin sulphation was assessed. Non-inflamed mucosa was associated with the highest percentage of sulphated mucin (Table 5). A significant reduction in the percentage sulphated mucin was observed in mucosa with moderate or severe inflammation compared to no inflammation
(p < 0.005) (Fig. 3b, Table 5). No difference was observed in the sulphomucin content between moderate and
severely inflamed mucosa (p = 1.00).

Correlations between mucin sulphation and A. muciniphila abundance. A positive association was
found between the abundance of A. muciniphila and a higher percentage of sulphated mucin (ρ 0.546, p = 0.000)
(Fig. 4, Table 6). This association was lost after normalisation of the data (ρ 0.164, p = 0.058).
Predictors of A. muciniphila abundance in health and ulcerative colitis. A summary of patient
characteristics is included in supplementary data. Details pertaining to patient demographics are outlined in
Supplementary Table 2. To determine whether patient demographic factors influenced A. muciniphila abundance,
multiple linear regression analysis was performed on all three patient cohorts (Supplementary Table 3). Data were
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Figure 3. (a) Boxplots representing the reduction in the proportion of sulphated mucin present in AC
compared to HC across four colonic regions. * indicates a p value of < 0.005 as determined by the Mann
Whitney U test. (b) Boxplots representing the proportion of sulphomucin present in mucosal samples based on
degree of inflammation.

Figure 4. Scatterplot depicting the relationship between A. muciniphila abundance and percentage sulphated
mucin present in samples. The acute UC cohort is represented by red, quiescent UC by orange and healthy
controls in green

Median %
Inflammatory cell infiltrate sulphomucin

IQR

None

1.55E + 2

9.14E + 2

Mild-Moderate

5.68E + 2

2.80E + 2

Severe

5.76E + 2

3.33E + 2

Correlation with A.
muciniphila abundance

Correlation
coefficient (ρ)

P value

0.546

<0.005

Table 5. Median percentage sulphomucin in inflamed and non-inflamed mucosa and Spearman Rho
correlations with A. muciniphila abundance.

log10 transformed prior to analysis to ensure the assumptions of linearity, homoscedasticity and normality were
met. Variables assessed included age, gender, smoking status (current, previous, non-smoker) and appendectomy
(yes, no). None of the variables examined were predictive of A. muciniphila abundance (F = 0.767, p = 0.558).
Regression coefficients and p values are outlined in Supplementary data.
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A separate analysis was performed on all patients with UC, combining the AC and QUC cohorts, to determine
whether drug treatment or Mayo score predicted A. muciniphila abundance. Using Spearman Rho correlation, a
negative correlation was noted between Mayo score and A. muciniphila abundance (ρ = −0.706, p < 0.005).
Multiple linear regression analysis was then performed to predict A. muciniphila abundance based on drug
treatments (aminosalicylates, biologics, steroids and antibiotics) and Mayo score (F = 7.487, p = 0.001). Mayo
score predicted lower A. muciniphila abundance (Supplementary Table 3). Abundance did not vary with treatment modality (Supplementary Table 3).

Discussion

A high rate of colonisation with A. muciniphila was observed in all three patient cohorts, indicating that this species is a common commensal inhabiting the MGL of the human colon. A. muciniphila has been widely detected
in faecal samples and mucosal biopsies1,3,26, however to the authors’ knowledge, this is the first study to quantitatively analyse this species in mucus brushings of the colonic mucus. No trend in A. muciniphila abundance was
evident along the longitudinal axis of the colon, in keeping with current literature supporting spatial homogeneity
of the commensal microbiota extending from caecum to rectum19.
These data indicate a reduction in the abundance of A. muciniphila within the MGL in AC compared to health
and are in keeping with the published literature10. In QUC, the abundance returns towards levels observed in the
healthy colon, suggesting that the reduced abundance is related to the inflammatory process, rather than being a
feature of the microbial signature of individuals suffering from UC. Normalisation of data against total bacterial
copy number reduced potential reporting errors by minimising the effect of between-sample variation and taking
the efficiency of the quantification procedure into account. These data are more representative of the actual burden of the target in the MGL. However, normalisation negated the significant difference in abundance observed
between health and acute UC when analysis was based on raw copy numbers. This is likely due to the fact that
A. muciniphila accounts for a small proportion (thought to be 1–3%) of the overall bacterial load in the colon1,3.
These estimates from the literature were based on analysis of faecal samples. The normalised data presented here
suggest that the overall abundance of this species in the MGL is lower than this.
The present study uses protected specimen brushings (PSB) of the colonic mucosa as the sampling method,
reducing potential contamination from luminal contents or mucosal associated bacteria during insertion and
withdrawal20, therefore the findings are likely to represent the true burden of these species within the MGL. It is
possible that the use of bowel preparation may have resulted in a loss of some loosely adherent microbes in the
patients undergoing colonscopy (healthy controls and quiescent cohorts), however, this would not account for the
low colonisation rates in patients with acute UC, as this cohort did not receive bowel preparation prior to surgery.
Despite the fact that the true burden of A. muciniphila in the colon is low, this microbe has the ability to affect host
gene expression,6,27 therefore alterations in the abundance of this species in disease states may nonetheless have
implications for the host.
Johansson et al., demonstrated that in UC, bacteria can penetrate the normally sterile inner layer of the
MGL28, a fact which should also be considered when interpreting these data and may account for the observed
reduction in A. muciniphila in the AC cohort.
It should be noted that all patients included in this study were fasting for a minimum of 24 hours prior to
biopsy collection. A. muciniphila does not rely on dietary substances for substrate and consequently is conferred
with a competitive advantage during periods of fasting29,30. The abundances reported here, therefore, may not be
truly representative of the normal healthy colon. This potential confounding factor would be difficult to eliminate,
as adequate bowel cleansing is a prerequisite for colonoscopy. Furthermore, as all three groups included in this
study were fasting, comparisons of the relative abundances between cohorts should not be affected.
The second aim of this study was to assess if a correlation exists between A. muciniphila and the degree of
mucin sulphation present in mucosal biopsies. One possible explanation for reduced abundance AC is a lack of
substrate. A. muciniphila has the capacity to produce sulfatases17 and may use sulphated mucin as their substrate.
Analysis of the sulphomucin profiles in the three cohorts indicated that the inflamed mucosa in acute UC was
associated with a significantly lower percentage of sulphomucin. Lower percentage of sulphomucin was associated with reduced A. muciniphila abundance, and multiple linear regression analysis revealed that percentage
sulphation significantly predicted A. muciniphila abundance, indicating a possible link between sulphomucin
content and A. muciniphila burden. These data lend support to the hypothesis that a lack of sulphomucin substrate may contribute to the reduced abundance of this microbe in the inflamed colon. Of note, a correlation
between the species Desulfovibrio, a species also capable of degrading sulphated mucin, and reduced sulphated
mucin in the colitic colon has previously been demonstrated lending support to the hypothesis that alterations in
mucin biochemistry may contribute of changes in the microbiota observed in UC15.
It is likely that the lack of sulphated mucin in AC is not the sole contributor to alterations in A. muciniphila
abundance. Other biochemical changes in mucin composition have been reported in UC, including reduced levels of MUC2 and alterations in glycosylation16,31, which may also influence microbial survival and proliferation.
The results also show that higher inflammatory scores were associated with reduced abundances of A. muciniphila. In keeping with this, the MAYO score was the only clinical parameter that was predictive of A. muciniphila
abundance. It is conceivable that bacterial growth inhibition resulting from the inflammatory process itself may
account for the reduced abundance of A. muciniphila in UC. The production of inflammatory mediators and
associated changes in the micro-environment may render the MGL a less hospitable niche for this commensal. UC is also associated with increased colonisation with opportunistic pathogens, such as members of the
Enterobacteriaceae family32, which could potentially lead to competitive exclusion of A. muciniphila. In vitro
studies have demonstrated growth inhibition of A. muciniphila in co-culture compared to pure culture, lending
support to this hypothesis10. In contrast to these findings however, one study in the literature reported exacerbation of Salmonella typhimurium induced inflammation in the presence of A. muciniphila33.
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In addition to mucin degradation10,17, A. muciniphila may have other functions which are beneficial to the host7,34–36.
Mechanisms that have been proposed include: production of essential SCFAs such as propionate and acetate as a result
of mucin degradation17, immunomodulation of the adaptive immune system6, protective barrier functions7,37 and
anti-inflammatory properties38. The role of A. muciniphila in modulating metabolic pathways has been well described
in obesity, diabetes and other cardiometabolic disorders4,27,35,39–41, conditions which, like UC, are associated with an
altered microbiota, inflammation and altered gut barrier function. Derangements in the abundance of this microbe
may have important metabolic implications in the colon and warrant further investigation in the setting of UC.
A. muciniphila may be involved in a positive feedback loop, whereby through mucin degradation it stimulates
mucin production and renewal of the MGL34. While this has not been described specifically in the context of UC,
evidence suggests that the species has the ability to ameliorate age related depletion of colonic mucus42 suggesting that this loop may exist at times of stress or disease states. If this hypothesis holds true, then reduced activity
of this species may represent a primary pathogenic mechanism in UC. In contrast to the described beneficial
actions, one study in murine models demonstrated a link between A. muciniphila colonisation and development
of colitis. However this may have been attributable to loss of host immune tolerance to commensal microbiota in
disease states, rather than a true pathogenic mechanism of A. muciniphila43.
Overall, this study lends support to the hypothesis that A. muciniphila is a symbiont member of the human
colonic microbiota and confirms an inverse relationship between its abundance in the MGL and active inflammation. The observed reduction in abundance may be the result of an altered micro-environment in the inflamed
colon itself, however these data lend support to the hypothesis that it is a consequence of reduced availability of
sulphated mucin substrate.
Received: 10 June 2019; Accepted: 3 October 2019;
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